Innopharma is Ireland’s leading provider of higher and further education, focused on up-skilling and re-skilling individuals to enter or progress within the pharmaceutical, medtech and food & beverage manufacturing sectors. It is also a provider of highly trained, contract technical resources to client companies within the pharmaceutical and medtech industries.
Innopharma is the largest private life science higher education institution in Ireland with courses being delivered nationwide across Dublin, Cork, Limerick and Galway. Its Education Division upskills and reskills over 1,700 learners annually and its Technical Services Division selects and trains technical contractors to the highest regulatory standards.
Given the skills required to support advanced manufacturing both in Ireland and internationally and the commitment of governments to support lifelong learning, the up-skilling and re-skilling education sector continues to expand apace. This creates market opportunities for well positioned and invested critical skills focused businesses, such as Innopharma.
Innopharma was looking for a partner with experience of working with, and helping to grow, dynamic scaling businesses. Preserving company culture and team was of critical importance and MML Ireland’s track record in providing the guidance and professionalisation required to expand and scale were a key component of the plan.
As part of the deal, MML partnered with the founder shareholder, Dr. Ian Jones, DunPort Capital Management, Orla Callan, Luke Kiernan and the wider Innopharma team in order to create an appropriate capital structure and set a platform for success in expanding in Ireland and internationally.
MML Ireland Fund II
Republic of Ireland
For investors in MML Ireland Fund I, MML Ireland Fund II & MML Fund VI
For investors in MML Fund VII